Gene clusters-based pathway enrichment analysis identifies four pan-cancer subtypes with distinct molecular and clinical features
Functional & Integrative Genomics · 2024-12 · 24 (6)
DOI: 10.1007/s10142-024-01501-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Functional & Integrative Genomics, online erschienen am 28.11.2024. Verfasst von Mengli Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, Pharmaceutical University, 211198, Nanjing, China. Hauptthemen laut MEDLINE: Neoplasms, Multigene Family. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: China Pharmaceutical University.
Abstract (Originalsprache)
Pathways-based clustering methods have been proposed to explore tumor heterogeneity. However, such methods are currently disadvantageous in that specific pathways need to be explicitly claimed. We developed the PathClustNet algorithm, a pathway-based clustering method designed to identify cancer subtypes. This method first detects gene clusters and identifies overrepresented pathways associated with them. Based on the pathway enrichment scores, it reveals cancer subtypes by clustering analysis. We applied the method to TCGA pan-cancer data and identified four pan-cancer subtypes, termed C1, C2, C3 and C4. C1 exhibited high metabolic activity, favorable survival, and the lowest TP53 mutation rate. C2 had high immune, developmental, and stromal pathway activities, the lowest tumor purity, and intratumor heterogeneity. C3, which overexpressed cell cycle and DNA repair pathways, was the most genomically unstable and had the highest TP53 mutation rate. C4 overrepresented neuronal pathways, with the lowest response rate to chemotherapy, but the highest tumor purity and genomic stability. Furthermore, age showed positive correlations with most pathways but a negative correlation with neuronal pathways. Smoking, viral infections, and alcohol use were found to affect the activities of neuron, cell cycle, immune, stromal, developmental, and metabolic pathway in varying degrees. The PathClustNet algorithm unveils a novel classification of pan-cancer based on metabolic, immune, stromal, developmental, cell cycle, and neuronal pathways. These subtypes display different molecular and clinical features to warrant the investigation of precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, Pharmaceutical University, 211198, Nanjing, China.
- Institute of Innovative Drug Discovery and Development, China Pharmaceutical University, 211198, Nanjing, China.
- Big Data Research Institute, China Pharmaceutical University, 211198, Nanjing, China.
- Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, Pharmaceutical University, 211198, Nanjing, China. xiaosheng.wang@cpu.edu.cn.
- Institute of Innovative Drug Discovery and Development, China Pharmaceutical University, 211198, Nanjing, China. xiaosheng.wang@cpu.edu.cn.
- Big Data Research Institute, China Pharmaceutical University, 211198, Nanjing, China. xiaosheng.wang@cpu.edu.cn.
Förderung
- China Pharmaceutical University
Zitieren
APA
Xu, M., Ai, H., Wang, D., & Wang, X. (2024). Gene clusters-based pathway enrichment analysis identifies four pan-cancer subtypes with distinct molecular and clinical features. Functional & Integrative Genomics, 24(6). https://doi.org/10.1007/s10142-024-01501-0
Vancouver
Xu M, Ai H, Wang D, Wang X. Gene clusters-based pathway enrichment analysis identifies four pan-cancer subtypes with distinct molecular and clinical features. Functional & Integrative Genomics. 2024;24(6). doi:10.1007/s10142-024-01501-0
BibTeX
@article{Xu2024,
author = {Xu, Mengli and Ai, Hongjing and Wang, Danni and Wang, Xiaosheng},
title = {Gene clusters-based pathway enrichment analysis identifies four pan-cancer subtypes with distinct molecular and clinical features},
journal = {Functional & Integrative Genomics},
year = {2024},
volume = {24},
number = {6},
doi = {10.1007/s10142-024-01501-0}
}
EUVIMED